SARMS RAD-140 CAS:1182367-47-0

Min.Order / FOB Price:Get Latest Price

1 Gram	FOB Price:USD 1.0000 -11.0000

1 Gram

FOB Price:USD 1.0000 -11.0000

RAD-140 1182367-47-0 SARMS

RAD140, from its internal nonsteroidal selective

androgen receptor modulator (“SARM”) discovery program, for full preclinical development as a

potential therapy for the treatment of age-related muscle loss (sarcopenia) and other

musculoskeletal conditions such as osteoporosis. Radius selected RAD140 from a series of

promising SARMs after it demonstrated exceptional selectivity for anabolic activity in well-

validated in vivo models. Radius expects to complete formal toxicology studies that will allow

This makes its usage significantly safer and more effective compared to traditional prohormones and anabolic steroids.

AICAR	2627-69-2	acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown
MK2866	841205-47-8	medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy.
MK-677	15972-10-0	A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly
LGD-4033	1165910-22-4	pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
GW501516	317318-70-0	For obesity, diabetes, dyslipidemia and cardiovascular disease
Andarine(S4)	401900-40-0	partial agonist, intended mainly for treatment of benign prostatic hypertrophy
SR9009	1379686-30-2	under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice
SR9011	1379686-30-2	For obesity, diabetes, dyslipidemia and cardiovascular disease
RAD140	1182367-47-0	New generation for gaining mass and cutting edges
YK11	366508-78-3 431579-34-9	a SARM and myostatin inhibitor in one
GHRP-2	158861-67-7	Growth Hormone Releasing Peptide-2
GHRP-6	87616-84-0	Growth Hormone Releasing Peptide-6
TB500	107761-42-2	Thymosin beta 4
SM130,686	/	/